Sandy Loreaux is listed as an executive officer and director on 2 SEC Form D filings by 1 issuer between May 2023 and Jul 2023: Bryn Pharma, Inc. (Lebanon, NJ — other health care — 2023; $43.5M reported sold to 246 investors).
What this means One deal on file with the SEC, filed Jul 2023. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside ANNE C. WHITAKER (2 shared filings), David Dworaczyk (2 shared filings), Jeff Hartness (2 shared filings), Jim Borneman (2 shared filings), Kate Soper Diaz (2 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Sandy. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Sandy Loreaux and found 2 differences: Offering amount changed between filings; No amendment in the last 12 months on an offering that may still be open.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.